Type1diabetes: Clinical Trials

4 trials for Type1diabetes, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4
Phase 12Completed 2

Follow Type1diabetes: new trials by email Literature Review of Type1diabetes trials Research Report on Type1diabetes

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Butyrate Adjuvant Therapy for Type 1 Diabetes
BKR-017 - Type1diabetes
Phase 1 / Phase 2CompletedMayo Clinic62022-07-282026-03-31
A Comparison of Postprandial Glucose After a MMTT, and the Metabolic Effects of Insulin Withdrawal in a Crossover Study in Subjects With Type 1 Diabetes
YG1699, Dapagliflozin - Diabetes, Diabetes Mellitus, Type 1
Phase 2CompletedYoungene Therapeutics Inc., Ltd.192021-06-172022-07-28
Evaluation of Coffee Therapy for Improvement of Renal Oxygenation
Starbucks® Cold brew - 325ml bottle - Type1diabetes, Type1 Diabetes Mellitus
Phase 2CompletedUniversity of Colorado, Denver102019-07-012022-02-15
Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes
ProTrans, Control - Type1diabetes
Phase 1 / Phase 2CompletedNextCell Pharma Ab152019-05-172025-03-07

Narrower conditions

Diabetes Mellitus, Type 1 (3)  ·  Diabetes Mellitus (2)  ·  Diabetes Complications (1)  ·  Diabetic Nephropathies (1)

Broader conditions

Autoimmune Diseases (3)  ·  Endocrine System Diseases (3)  ·  Glucose Metabolism Disorders (3)  ·  Immune System Diseases (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Diabetes Mellitus (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Kidney Diseases (1)  ·  Male Urogenital Diseases (1)  ·  Urogenital Diseases (1)  ·  Urologic Diseases (1)

Interventions

Butyrates (1)  ·  Transplantation, Homologous (1)  ·  dapagliflozin (1)

Sponsors

Mayo Clinic (1)  ·  NextCell Pharma Ab (1)  ·  University of Colorado, Denver (1)  ·  Youngene Therapeutics Inc., Ltd. (1)

Countries

United States (3)  ·  Sweden (1)

Top investigators

Adrian Vella, MD (1)  ·  Per-Ola Carlsson, PhD (1)  ·  Petter Bjornstad, MD (1)

Results publications

PMID 38456487

NIH funding

2018 (1)